≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Special screening examination for neoplasms

DOID Endpoint Browser

Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z12
  • Cause of death: ICD-10 — Z12

2 out of 7 registries used, show all original rules.

1841

4. Check minimum number of events

None

1841

5. Include endpoints

None

1841

6. Filter based on genotype QC (FinnGen only)

1841

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[0-1]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1841 687 1154
Unadjusted period prevalence (%) 0.41 0.23 0.51
Median age at first event (years) 62.47 60.09 63.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1514
Matched controls
15140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
4018.7
323.0
556
*
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
471.8
323.0
649
24
TKE00
NOMESCO Finland
Needle biopsy of prostate
20.6
288.0
450
304
Z01.8
ICD-10 Finland
Other specified special examinations
10.5
125.1
259
292
UJF32
NOMESCO Finland
Coloscopy
4.2
116.7
556
1830
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
24.0
101.0
146
67
C61
ICD-10 Finland
Malignant neoplasm of prostate
4.5
95.9
401
1132
XJH00
NOMESCO Finland
Transanal ultrasonography
5.8
93.7
294
605
UJF30
NOMESCO Finland
Ileoscopy through colon
7.0
93.6
249
412
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
8.4
88.7
207
280
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
4.3
86.0
374
1082
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
85.9
80.0
89
11
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
50.8
75.6
91
19
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
391.0
75.4
75
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
10.4
74.5
152
161
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
7.8
72.7
177
253
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
12.2
71.7
134
119
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
6.5
63.6
176
301
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
62.7
458
1926
R4110
NOMESCO Finland
Physiotherapy
2.7
58.3
525
2495
Z12.8
ICD-10 Finland
Special screening examination for neoplasms of other sites
+∞
57.7
55
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
54.2
210
525
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
39.5
53.9
68
18
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
25.2
49.7
70
29
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
471.4
46.5
46
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.6
44.5
120
196
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
450.1
44.4
44
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.4
42.6
134
266
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
40.3
335
1469
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.8
40.1
183
527
WX002
NOMESCO Finland
Sedation and analgesia
2.5
38.6
354
1633
Z31.5
ICD-10 Finland
Genetic counselling
6.0
36.1
104
185
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.4
35.7
349
1659
XKD00
NOMESCO Finland
Uroflowmetry
2.4
35.2
365
1785
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
8.2
34.3
78
99
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
33.2
287
1272
ZXA00
NOMESCO Finland
Right side
2.1
32.3
439
2424
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
73.5
32.0
36
5
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
6.9
31.7
81
123
Z12.0
ICD-10 Finland
Special screening examination for neoplasm of stomach
+∞
31.3
30
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.4
30.6
159
505
116
Kela drug reimbursment
Prostate cancer
3.1
30.5
182
639
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
17.9
30.2
47
27
Z71.8
ICD-10 Finland
Other specified counselling
2.4
30.2
308
1479
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
3.8
29.9
132
367
J01MA02
ATC
ciprofloxacin; systemic
1.9
28.9
581
3711
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.1
28.5
117
305
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
27.9
439
2547
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
27.7
303
1502
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.2
27.6
154
513
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
27.2
332
1725
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
6.0
27.0
76
132
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
14.0
26.4
45
33
J01DB01
ATC
cefalexin; oral
1.9
25.5
1112
9053
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.2
25.3
69
115
A02BC02
ATC
pantoprazole; systemic
1.8
25.1
873
6583
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
24.8
400
2323
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
24.0
426
2560
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
12.7
23.6
42
34
ZXA05
NOMESCO Finland
Left side
2.0
23.4
388
2268
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
23.0
201
883
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
23.0
322
1764
N02AX02
ATC
tramadol; systemic, rectal
1.8
22.8
578
3905
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
22.8
614
4232
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
8.4
22.2
49
60
L02AE02
ATC
leuprorelin; implant, parenteral
3.0
21.5
127
441
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
21.3
266
1384
XCK10
NOMESCO Finland
Photography of fundus of eye
2.8
21.2
147
566
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
20.1
244
1252
Z00.0
ICD-10 Finland
General medical examination
2.4
20.1
180
800
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
19.8
290
1606
Z12.9
ICD-10 Finland
Special screening examination for neoplasm, unspecified
+∞
19.8
19
*
127
Kela drug reimbursment
Transplant complication
11.1
19.2
36
33
J01CA04
ATC
amoxicillin; systemic
1.7
19.0
1064
8838
Z94.0
ICD-10 Finland
Kidney transplant status
16.1
18.8
30
19
XF402
NOMESCO Finland
ECG with work load test
2.5
18.8
156
666
J01EA01
ATC
trimethoprim; systemic
1.9
18.3
301
1737
N40
ICD-10 Finland
Hyperplasia of prostate
1.7
18.3
434
2830
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
18.3
110
387
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
25.4
18.2
25
10
UKC02
NOMESCO Finland
Cystoscopy
2.0
18.2
277
1552
L02BB03
ATC
bicalutamide; oral
3.5
17.8
86
258
Z04.3
ICD-10 Finland
Examination and observation following other accident
96.1
17.6
19
*
A98
ICPC
Health maint/preventive medicine
1.9
17.3
1331
11957
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.8
17.1
43
65
N02BE01
ATC
paracetamol; systemic, rectal
1.7
16.6
1154
9941
DFF00
NOMESCO Finland
Pure tone audiometry
3.2
16.1
86
279
Z01.7
ICD-10 Finland
Laboratory examination
2.4
15.9
141
622
G04BE03
ATC
sildenafil; oral
5.8
15.8
44
77
A02BC05
ATC
esomeprazole; systemic
1.6
15.5
494
3471
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.5
15.4
123
512
WX110
NOMESCO Finland
Local anesthesy
1.5
15.1
851
6864
R31
ICD-10 Finland
Unspecified haematuria
2.1
14.7
186
965
N03AX16
ATC
pregabalin; oral
1.8
14.4
261
1549
L04AA06
ATC
mycophenolic acid; systemic
7.8
14.1
32
42
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
14.0
456
3204
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
13.9
133
609
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.6
13.8
107
438
B01AB05
ATC
enoxaparin; parenteral
1.6
13.6
395
2686
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
16.4
13.5
21
13
R53
ICD-10 Finland
Malaise and fatigue
1.8
13.4
241
1421
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
26.0
13.4
18
7
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
13.3
124
561
G04CA02
ATC
tamsulosin; oral
1.6
13.3
433
3033
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
13.0
190
1042
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
19.2
12.9
19
10
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
50.4
12.8
15
*
J01FA06
ATC
roxithromycin; oral
1.5
12.8
503
3685
J01AA02
ATC
doxycycline; systemic
1.5
12.5
1033
8877
A28
ICPC
Limited function/disability NOS
1.9
12.5
206
1177
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
12.5
96
393
S18
ICPC
Laceration/cut
1.5
12.5
515
3811
M79.6
ICD-10 Finland
Pain in limb
1.6
12.4
388
2682
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
12.4
482
3517
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
12.3
81
303
E0000UV
ATC
NA
1.5
12.2
455
3286
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.1
542
4081
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.0
12.1
69
236
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
26.9
12.0
16
6
XF404
NOMESCO Finland
Ambulatory ECG
2.2
12.0
120
560
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
11.9
200
1152
R33
ICD-10 Finland
Retention of urine
2.0
11.6
150
785
H02AB04
ATC
methylprednisolone; systemic
1.9
11.5
171
942
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
11.5
311
2068
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.4
11.4
55
167
J01FF01
ATC
clindamycin; systemic
1.6
11.4
322
2163
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
11.4
412
2940
ZXA10
NOMESCO Finland
Bilateral
1.7
11.4
246
1530
WX320
NOMESCO Finland
Spinalanesthesy
1.6
11.3
309
2058
J01MA12
ATC
levofloxacin; systemic
1.7
11.1
256
1623
JN4BD
NOMESCO Finland
Extensive body CT
1.9
11.1
168
930
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.8
11.1
218
1318
L28
ICPC
Limited function/disability (L)
1.8
11.0
196
1149
M25.5
ICD-10 Finland
Pain in joint
1.6
11.0
292
1926
P01AB01
ATC
metronidazole; oral, rectal
1.5
11.0
453
3330
M01AH01
ATC
celecoxib; oral (coxibs)
1.8
10.9
215
1303
-60
ICPC
Result test/procedure
2.5
10.9
86
357
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
43.6
10.9
13
*
XQ800
NOMESCO Finland
Prick test
3.5
10.9
50
147
N30.0
ICD-10 Finland
Acute cystitis
2.0
10.9
137
709
L02AE03
ATC
goserelin; implant
4.9
10.8
34
70
L17
ICPC
Foot/toe symptom/complaint
1.6
10.8
287
1897
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
9.7
10.8
21
22
R55
ICD-10 Finland
Syncope and collapse
1.9
10.7
150
809
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
10.7
216
1316
R06.0
ICD-10 Finland
Dyspnoea
1.6
10.7
286
1892
H02AB07
ATC
prednisone; oral
1.8
10.7
182
1051
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
10.6
84
349
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
60.4
10.6
12
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
10.6
129
659
ZX120
NOMESCO Finland
Intravenous
2.1
10.5
117
573
C07AB07
ATC
bisoprolol; oral
1.4
10.5
640
5093
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
10.4
39
96
G03HA01
ATC
cyproterone; systemic
5.9
10.4
28
48
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
10.4
133
691
WVA20
NOMESCO Finland
Medicine administration
3.6
10.3
45
127
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
10.3
342
2385
XG410
NOMESCO Finland
Flow-volume spirometry
3.5
10.3
47
138
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.7
10.2
252
1625
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
10.2
249
1602
ZXC20
NOMESCO Finland
Use of chemical agents
3.7
10.2
44
123
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.5
10.2
23
31
R42
ICD-10 Finland
Dizziness and giddiness
1.7
10.2
244
1566
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
13.2
10.2
17
13
UJH02
NOMESCO Finland
Anoscopy
3.3
10.1
50
156
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.0
10.1
22
28
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
9.9
120
612
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.4
9.9
46
137
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
9.9
57
197
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.9
189
1130
N17
ICPC
Vertigo/dizziness
2.0
9.9
123
631
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
16.8
9.9
15
9
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
9.8
93
424
L14
ICPC
Leg/thigh symptom/complaint
2.3
9.8
86
380
WZA90
NOMESCO Finland
Other doctors statement
1.7
9.8
239
1540
Z49.2
ICD-10 Finland
Other dialysis
10.7
9.8
18
17
UJD02
NOMESCO Finland
Gastroscopy
2.7
9.7
65
246
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
9.7
37
93
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
9.7
586
4635
G04BD08
ATC
solifenacin; oral
2.3
9.6
89
402
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
9.6
154
872
R05
ICD-10 Finland
Cough
1.7
9.6
217
1368
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.2
9.6
96
450
B05DA
ATC
Isotonic solutions
9.1
9.5
19
21
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
15.1
9.5
15
10
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
9.5
136
737
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
9.5
138
755
WX402
NOMESCO Finland
General anaesthesia
1.7
9.4
217
1373
K03.64
ICD-10 Finland
Dental calculus supragingival
1.6
9.4
280
1896
L03
ICPC
Low back symptom/complaint
1.7
9.4
227
1455
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
9.3
135
737
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
9.3
66
259
M03BX02
ATC
tizanidine; oral
1.4
9.2
706
5809
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
9.2
78
336
UJF92
NOMESCO Finland
Capsular endoscopy
5.9
9.1
24
41
G04BE01
ATC
alprostadil; parenteral, urethral
3.1
9.0
47
154
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
9.0
161
947
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.6
8.9
61
236
137
Kela drug reimbursment
Uraemia requiring dialysis
7.5
8.9
20
27
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
8.9
61
237
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.8
796
6719
A46
ICD-10 Finland
Erysipelas
1.7
8.8
178
1084
N03AX12
ATC
gabapentin; oral
1.8
8.8
149
861
Z50.1
ICD-10 Finland
Other physical therapy
2.6
8.7
63
251
D12
ICPC
Constipation
3.2
8.7
43
136
Y06
ICPC
Prostate symptom/complaint
2.6
8.7
59
228
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
8.6
92
445
R01AD09
ATC
mometasone; nasal
1.4
8.6
463
3562
N06AX11
ATC
mirtazapine; oral
1.5
8.5
330
2369
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
16.4
8.5
13
8
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
8.5
154
907
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
10.1
8.5
16
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.5
96
477
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
27.7
8.5
11
*
M54.5
ICD-10 Finland
Low back pain
1.5
8.5
320
2288
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
8.5
852
7309
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
8.5
206
1323
A04
ICPC
Weakness/tiredness general
1.9
8.5
128
710
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
8.4
70
301
K29.3
ICD-10 Finland
Chronic superficial gastritis
3.2
8.4
42
134
C08CA01
ATC
amlodipine; oral
1.4
8.3
475
3689
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.6
8.3
36
103
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
8.2
204
1317
C03CA01
ATC
furosemide; systemic
1.4
8.2
395
2967
E66.8
ICD-10 Finland
Other obesity
2.8
8.2
50
182
R74
ICPC
Upper respiratory infection acute
1.6
8.2
257
1758
J01FA10
ATC
azithromycin; systemic
1.4
8.2
625
5108
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.8
8.2
147
865
A91
ICPC
Abnormal result investigation NOS
2.6
8.1
59
235
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
8.1
365
2704
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
8.1
106
559
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
8.1
267
1849
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
33.5
8.1
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
17.3
8.1
12
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
17.3
8.1
12
7
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.9
8.1
19
28
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
8.1
91
453
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
8.1
56
220
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.7
8.1
33
90
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
8.0
113
613
R60.0
ICD-10 Finland
Localized oedema
1.8
8.0
135
779
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
3.4
8.0
37
112
R13
ICD-10 Finland
Dysphagia
2.3
7.9
73
333
R4120
NOMESCO Finland
Occupational therapy
2.2
7.9
82
392
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
7.9
191
1226
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
7.9
77
358
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
6.1
7.8
20
33
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.8
786
6705
Y77
ICPC
Malignant neoplasm prostate
2.4
7.8
63
267
R04.0
ICD-10 Finland
Epistaxis
2.0
7.7
97
503
K30
ICD-10 Finland
Functional dyspepsia
1.9
7.7
105
561
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
4.3
7.7
27
64
N05CF01
ATC
zopiclone; oral
1.4
7.6
380
2869
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.8
7.6
24
51
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
18.4
7.6
11
6
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
18.4
7.6
11
6
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
7.6
85
422
A06AC51
ATC
ispaghula, combinations; systemic
2.6
7.6
53
210
K63.5
ICD-10 Finland
Polyp of colon
5.2
7.6
22
43
J01CA08
ATC
pivmecillinam; oral
1.4
7.5
350
2604
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
7.5
107
581
ULA02
NOMESCO Finland
Kolposcopy
2.1
7.4
80
391
D07AC01
ATC
betamethasone; topical
1.4
7.4
403
3085
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
7.4
67
302
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.4
371
2801
H93.1
ICD-10 Finland
Tinnitus
2.2
7.4
70
323
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
6.5
7.4
18
28
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
13.4
7.4
12
9
D11
ICPC
Diarrhoea
1.9
7.4
100
534
DFF15
NOMESCO Finland
Speech audiometry
3.9
7.4
28
72
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
7.4
88
449
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
7.3
87
441
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
7.3
339
2525
C10AA01
ATC
simvastatin; oral
1.4
7.2
605
4984
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.0
7.2
38
127
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.2
285
2052
R03AC02
ATC
salbutamol; inhalant
1.4
7.2
573
4686
WX892
NOMESCO Finland
Monitored bed care
1.9
7.2
104
568
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
30.1
7.1
9
*
B05DB
ATC
Hypertonic solutions
8.0
7.1
15
19
R5110
SPAT
NA
3.1
7.1
37
123
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
7.1
37
123
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.1
7.0
13
13
D02AE01
ATC
carbamide; topical
2.1
7.0
72
345
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.6
7.0
200
1340
R03BA02
ATC
budesonide; inhalant
1.6
7.0
182
1192
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.9
149
925
L04AD01
ATC
ciclosporin; systemic
4.3
6.9
24
57
U08
ICPC
Urinary retention
3.1
6.8
35
115
V03AE02
ATC
sevelamer; oral
8.3
6.8
14
17
L29.9
ICD-10 Finland
Pruritus, unspecified
3.5
6.8
30
88
TK820
NOMESCO Finland
Peritoneal dialysis
11.0
6.8
12
11
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
6.8
177
1156
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
9.3
6.8
13
14
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
6.8
54
229
N99.1
ICD-10 Finland
Postprocedural urethral stricture
6.1
6.8
17
28
L01
ICPC
Neck symptom/complaint
1.8
6.8
119
695
N76.4
ICD-10 Finland
Abscess of vulva
16.8
6.7
10
6
H02
ICPC
Hearing complaint
1.7
6.7
141
870
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
6.7
583
4817
J20
ICD-10 Finland
Acute bronchitis
1.8
6.7
105
592
A11CC03
ATC
alfacalcidol; systemic
3.2
6.7
32
100
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
6.7
302
2230
L16
ICPC
Ankle symptom/complaint
1.9
6.7
93
504
M01AB05
ATC
diclofenac; systemic, rectal
1.3
6.7
810
7033
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
22.6
6.7
9
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
3.3
6.7
31
95
P03
ICPC
Feeling depressed
2.3
6.7
57
252
F51.0
ICD-10 Finland
Nonorganic insomnia
1.8
6.6
109
624
A97
ICPC
No disease
1.6
6.6
175
1147
TK800
NOMESCO Finland
Hemodialysis
3.3
6.6
31
96
WX140
NOMESCO Finland
Parabulbar anesthesy
2.2
6.6
64
300
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
6.6
103
578
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.8
6.6
26
70
L84
ICD-10 Finland
Corns and callosities
2.8
6.6
39
141
C50.99
ICD-10 Finland
Breast, unspecified
3.3
6.6
30
91
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
6.5
69
336
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
4.8
6.5
20
42
U14
ICPC
Kidney symptom/complaint
3.7
6.5
26
71
S21
ICPC
Skin texture symptom/complaint
1.7
6.5
143
895
A08
ICPC
Swelling
2.4
6.5
50
211
R5120
NOMESCO Finland
Preparation of an aid
3.4
6.4
29
87
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
6.4
58
263
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
6.4
87
467
V03AE01
ATC
polystyrene sulfonate; oral
4.3
6.4
22
52
A02BA02
ATC
ranitidine; systemic
1.5
6.4
237
1681
N06AB04
ATC
citalopram; systemic
1.5
6.4
208
1434
R03BA05
ATC
fluticasone; inhalant
1.6
6.4
179
1190
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
6.4
284
2088
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.4
596
4968
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.2
6.4
60
278
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.2
6.3
13
16
LCA06
NOMESCO Finland
Biopsy of endometrium
1.8
6.3
103
589
Z00.8
ICD-10 Finland
Other general examinations
2.3
6.3
54
238
G04BE08
ATC
tadalafil; oral
11.1
6.3
11
10
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.0
6.3
75
382
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
6.3
6
*
R52.9
ICD-10 Finland
Pain, unspecified
1.9
6.2
81
427
R51.80
ICD-10 Finland
Headache
1.7
6.2
113
670
-62
ICPC
Administrative procedure
2.7
6.2
40
150
C10AA05
ATC
atorvastatin; oral
1.3
6.2
502
4093
A03FA02
ATC
cisapride; oral, rectal
1.9
6.2
85
460
N39.3
ICD-10 Finland
Stress incontinence
2.2
6.2
58
267
R4130
NOMESCO Finland
Speech therapy
3.2
6.2
30
96
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
6.1
90
495
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.9
6.1
88
480
A06AD11
ATC
lactulose; oral
1.6
6.1
173
1155
R07.3
ICD-10 Finland
Other chest pain
1.8
6.1
94
528
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.1
376
2934
N06AX16
ATC
venlafaxine; oral
1.8
6.1
108
634
R52.2
ICD-10 Finland
Other chronic pain
3.3
6.1
28
86
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
6.0
374
2919
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.0
6.0
31
103
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.6
6.0
40
155
K56.7
ICD-10 Finland
Ileus, unspecified
3.5
6.0
26
76
H29
ICPC
Ear symptom/complaint other
1.8
6.0
104
607

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
506
2137
2.89
81.81
3.2
2.9
e6/l
1.4
1.9
0.81
286
1084
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
491
2248
2.61
66.03
3.2
2.8
e6/l
0.8
1.2
2.48
269
1185
(3033658) Prothrombin time (PT) actual/Normal
664
3528
2.38
64.37
4.7
3.6
%
84.7
87.0
1.38
649
3455
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
867
5173
2.28
63.78
2.3
1.9
pmol/l
95.3
92.3
0.97
421
2724
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
940
6307
2.00
45.74
10.1
6.0
mmol/l
1.2
1.2
0.05
820
5082
(3022096) Basophils/100 leukocytes in Blood
861
5620
2.00
45.14
6.4
5.3
%
0.7
0.7
0.23
783
5199
(42870588) Differential panel, method unspecified - Blood
705
4297
2.04
44.77
6.2
5.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
327
1484
2.46
42.99
31.5
28.0
inr
1.4
1.4
0.19
31
158
(3019069) Monocytes/100 leukocytes in Blood
873
5815
1.95
42.28
6.6
5.4
%
9.2
8.8
3.16
795
5395
(3018010) Neutrophils/100 leukocytes in Blood
877
5862
1.95
41.92
6.2
5.1
%
58.9
58.0
1.47
797
5438
(3006504) Eosinophils/100 leukocytes in Blood
869
5794
1.95
41.82
6.3
5.2
%
2.9
2.8
0.12
789
5350
(3030467) Casts [#/volume] in Urine by Automated count
642
3858
2.02
41.78
3.8
2.9
e6/l
0.3
0.6
2.13
460
2803
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
535
3011
2.10
41.66
2.7
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
297
1318
2.49
40.84
1.4
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
622
3736
2.00
40.23
3.8
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
682
4233
1.97
40.11
3.9
3.0
e6/l
95.9
121.5
0.29
511
3160
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
873
5893
1.92
39.87
8.0
5.6
mmol/l
1.2
1.2
0.06
759
5328
(3002030) Lymphocytes/100 leukocytes in Blood
882
5995
1.90
39.23
6.5
5.3
%
25.7
26.9
2.17
802
5537
(3024561) Albumin [Mass/volume] in Serum or Plasma
843
5649
1.91
39.15
7.1
4.5
g/l
35.1
34.9
0.37
781
5193
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
455
2463
2.13
38.89
3.8
3.4
ng/l
1077.5
603.7
0.38
377
2041
(3013115) Eosinophils [#/volume] in Blood
915
6319
1.89
38.50
6.5
5.2
e9/l
0.2
0.2
0.33
741
5350
(3006315) Basophils [#/volume] in Blood
889
6126
1.87
37.25
6.1
5.0
e9/l
0.0
0.0
1.14
714
5063
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
737
4786
1.90
37.15
2.3
2.0
nmol/l
78.9
76.5
1.33
621
4217
(3044640) Blood type and Crossmatch panel - Blood
660
4135
1.93
37.10
2.8
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
886
6106
1.87
37.04
6.1
5.0
e9/l
0.6
0.6
0.24
706
5038
(40768804) Tissue Pathology biopsy report
780
5170
1.88
36.80
2.6
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1506
12412
2.17
36.04
22.3
14.2
%
39.6
39.7
0.18
1154
8578
(3018095) Leukocytes [#/volume] in Urine
734
4799
1.88
35.92
4.4
3.4
e6/l
74.0
120.7
0.92
533
3353
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
253
1112
2.48
35.23
3.3
2.3
u/l
37.0
46.4
0.61
217
951
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
930
6574
1.84
35.22
7.3
6.1
umol/l
12.2
12.4
0.19
879
6211
(3031040) Bacteria [#/volume] in Urine by Automated count
1134
8526
1.86
35.10
4.9
3.9
e6/l
4.2
2389.0
—
5
203
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1298
10192
1.93
35.02
9.5
6.9
u/l
81.9
80.7
0.31
1217
9477
(40768797) Stomach Pathology biopsy report
305
1467
2.29
34.61
1.4
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
897
6308
1.82
34.21
6.1
5.1
e9/l
1.7
1.9
2.43
736
5353
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
290
1388
2.29
33.21
3.4
2.6
umol/l
6.9
10.2
2.89
260
1209
(4146454)
42
49
8.75
33.21
3.4
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
991
7277
1.78
31.82
9.6
8.3
e9/l
4.1
4.3
1.27
809
6105
(40768800) Prostate Pathology biopsy report
134
448
3.15
31.36
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
516
3127
1.90
31.05
7.4
6.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1574
13476
2.16
29.82
19.4
12.9
mg/l
28.2
27.5
0.31
1280
10445
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1441
11988
1.93
29.19
4.8
4.0
mu/l
1.9
2.4
1.55
1260
10700
(3019225) pH of Specimen
226
1026
2.37
29.06
10.3
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1515
12868
2.00
28.15
18.7
13.2
ml/min/173m2
77.5
78.0
0.42
1250
10508
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
173
704
2.61
28.10
1.7
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
26
20
13.17
27.16
6.8
4.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1136
8904
1.72
26.90
5.2
3.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
733
5113
1.72
26.68
3.6
2.5
ug/l
176.7
156.3
0.44
659
4674
(3015377) Calcium [Moles/volume] in Serum or Plasma
650
4415
1.73
25.85
4.1
3.5
mmol/l
2.4
2.3
0.34
532
3897
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
506
3200
1.80
25.79
2.8
2.0
mg/l
2.9
2.9
0.06
423
2695
(3014111) Lactate [Moles/volume] in Serum or Plasma
236
1153
2.20
25.36
7.8
7.1
mmol/l
1.4
1.3
0.09
221
1110
(3000991) Gas panel - Venous blood
235
1151
2.19
25.08
9.0
8.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1012
7792
1.66
24.66
6.0
4.4
mmol/l
6.7
6.8
0.78
945
7274
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
833
6109
1.66
24.48
4.1
3.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1177
9443
1.68
24.29
4.4
3.4
mm/h
13.3
12.7
0.68
1056
8619
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
580
3902
1.71
23.39
3.8
3.1
ug/l
1.0
0.8
2.86
412
2665
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
347
2014
1.89
23.01
1.9
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
107
378
2.94
22.72
6.9
3.5
mmol/l
24.3
24.9
1.68
97
344
(3014576) Chloride [Moles/volume] in Serum or Plasma
305
1707
1.94
22.54
8.7
7.1
mmol/l
104.6
104.7
0.11
298
1664
(3021960) Folate [Moles/volume] in Serum or Plasma
476
3060
1.75
22.46
1.6
1.5
nmol/l
20.8
20.0
0.48
400
2577
(3019550) Sodium [Moles/volume] in Serum or Plasma
1610
14270
2.02
22.19
23.3
15.2
mmol/l
139.5
139.7
2.26
1556
13810
(3026782) Osmolality of Urine
450
2858
1.76
22.11
3.0
2.5
mosm/kgh2o
593.2
570.1
1.23
384
2405
(3023103) Potassium [Moles/volume] in Serum or Plasma
1612
14318
2.01
21.71
23.5
15.4
mmol/l
4.0
4.0
1.31
1554
13839
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1058
8399
1.61
21.48
3.6
2.7
u/l
58.0
51.4
1.38
972
7718
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1638
14647
2.07
21.41
12.7
9.2
u/l
26.7
26.4
0.18
1554
13995
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
555
3765
1.68
21.32
2.1
2.0
u/l
218.7
223.0
0.04
513
3494
(40761536) Microorganisms panel - Urine sediment
38
1541
0.23
21.00
3.2
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
560
3823
1.67
20.93
4.5
4.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
143
611
2.45
20.88
2.5
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
143
613
2.45
20.73
4.6
3.8
mmol/l
23.9
24.0
0.12
134
541
(3032080) INR in Blood by Coagulation assay
762
5627
1.60
20.69
10.1
10.3
inr
1.3
1.3
0.15
108
1772
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
118
465
2.64
20.38
2.4
3.0
u/ml
0.3
0.3
0.28
55
248
(3003338) MCHC [Mass/volume]
1362
11579
1.68
20.34
24.2
16.4
g/l
331.5
332.5
4.59
1349
11461
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
271
1511
1.93
20.11
3.6
4.0
u/l
264.2
244.8
0.59
252
1420
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
247
1335
1.98
20.07
6.2
4.2
%
32.4
32.7
0.09
111
863
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
88
301
3.02
19.79
2.3
2.4
%
194.0
198.7
0.19
81
289
(3024471) HLA-A [Type]
23
24
9.69
19.69
1.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
301
1749
1.86
19.65
3.4
2.3
%
22.6
23.3
0.31
258
1496
(3020779) Urea [Moles/volume] in Serum or Plasma
220
1161
2.02
19.09
11.9
6.1
mmol/l
11.8
10.9
0.89
208
1106
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
159
741
2.25
19.03
9.7
9.4
mmol/l
24.2
24.3
0.08
148
695
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
858
6604
1.56
18.95
6.7
5.0
ug/l
4.0
3.3
0.98
710
5837
(3024932) HLA-DR beta [Type]
22
23
9.67
18.79
1.0
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
284
1649
1.85
18.51
9.6
5.0
mmol/l
1.1
1.0
1.28
257
1530
(3022948) Iron [Moles/volume] in Serum or Plasma
326
1983
1.78
18.21
3.4
2.3
umol/l
11.8
13.0
2.30
300
1830
(3004789) Transferrin [Mass/volume] in Serum or Plasma
309
1852
1.80
18.14
3.3
2.3
g/l
2.2
2.2
0.70
284
1703
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
257
1457
1.89
18.03
4.3
4.3
ug/l
16.6
14.7
0.06
210
1195
(3027945) Reticulocytes/100 erythrocytes in Blood
268
1540
1.87
18.02
2.8
2.3
%
1.7
1.7
0.25
223
1360
(3022313) Gas panel - Capillary blood
113
465
2.52
17.87
6.5
3.3
—
—
—
0
0
(3036489) Thrombin time
107
430
2.58
17.77
1.9
1.9
s
23.6
21.1
0.63
97
379
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
254
1441
1.88
17.76
1.8
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1588
14257
1.83
17.52
17.4
12.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
571
4063
1.59
17.42
3.9
2.9
u/l
37.5
34.9
0.31
533
3839
(3007461) Platelets [#/volume] in Blood
1675
15307
2.05
17.41
28.2
18.9
e9/l
240.2
243.7
1.44
1614
14752
(3024731) MCV [Entitic volume]
1675
15315
2.04
17.26
28.1
18.8
fl
91.5
91.4
0.45
1638
14999
(3035941) MCH [Entitic mass]
1675
15316
2.04
17.24
28.1
18.8
pg
30.4
30.5
0.18
1638
14999
(3026361) Erythrocytes [#/volume] in Blood
1675
15318
2.04
17.20
28.2
18.8
e12/l
4.4
4.5
2.94
1612
14709
(3000963) Hemoglobin [Mass/volume] in Blood
1675
15320
2.04
17.16
28.4
19.0
g/l
133.9
135.9
5.84
1637
15008
(3010813) Leukocytes [#/volume] in Blood
1675
15320
2.04
17.16
28.3
18.9
e9/l
6.7
6.8
0.52
1605
14696
(3012095) Magnesium [Moles/volume] in Serum or Plasma
338
2112
1.74
17.11
3.7
3.0
mmol/l
0.8
0.8
1.71
310
1968
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
251
1437
1.86
17.03
1.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
382
2473
1.69
16.97
1.8
1.7
mg/l
2.4
1.3
1.76
296
1924
(3026493) Urate [Moles/volume] in Serum or Plasma
507
3553
1.59
16.31
3.8
2.5
umol/l
7840.6
7040.3
0.12
424
3026
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
90
347
2.68
16.25
2.0
2.1
%
88.8
88.0
0.11
84
325
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
532
3778
1.57
16.14
3.1
2.8
ng/l
1774.1
1672.2
0.15
437
3230
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
434
2.48
15.97
3.4
2.3
g/l
3.3
3.2
0.28
82
359
(36660697) Celiac disease serology panel - Serum
150
733
2.14
15.93
1.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
428
2897
1.62
15.85
2.8
2.4
e6/l
4.0
5.5
1.62
368
2504
(3007164) IgA [Mass/volume] in Serum or Plasma
315
1973
1.72
15.70
1.4
1.4
g/l
2.6
2.6
0.04
163
1201
(3042936) Bacteria identified in Isolate by Culture
294
1807
1.75
15.68
2.3
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
378
2492
1.65
15.52
3.6
3.3
mmol/l
2.4
2.5
0.61
325
2181
(3019309) Folate [Moles/volume] in Red Blood Cells
380
2512
1.65
15.42
1.7
1.8
nmol/l
900.4
1199.9
9.46
244
1858
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
19
5
38.39
15.39
8.7
3.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1322
11455
1.55
15.27
23.6
16.4
%
13.8
13.7
0.50
1302
11111
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1434
12681
1.59
14.89
6.8
5.4
mmol/mol
39.8
39.9
0.20
1282
11529
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
470
2.36
14.70
3.3
2.3
g/l
7.5
7.4
0.21
82
362
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
470
2.36
14.70
3.3
2.3
g/l
3.8
3.9
0.51
80
349
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
470
2.36
14.70
3.3
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
514
3690
1.55
14.60
3.0
2.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
199
1110
1.89
14.57
2.1
2.1
ug/g
137.7
161.1
0.44
145
901
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
125
592
2.19
14.37
1.7
1.6
g/l
1.5
1.5
0.03
103
509
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1606
14651
1.75
14.34
22.5
15.6
umol/l
84.9
81.0
2.76
1606
14644
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
156
807
2.02
14.23
6.6
3.8
ng/l
119.3
96.3
1.13
132
699
(3002032) Base excess in Venous blood by calculation
212
1216
1.84
14.20
4.3
3.5
mmol/l
1.3
1.7
0.72
180
966
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
234
1388
1.79
14.03
6.1
6.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
315
2031
1.66
13.97
2.3
1.9
s
30.1
30.3
0.28
305
1973
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
178
971
1.92
13.93
2.1
2.2
ug/l
6.3
7.6
0.64
142
857
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1536
13890
1.64
13.66
5.4
4.8
mmol/l
2.6
2.7
4.63
1364
12605
(3021447) Carbon dioxide [Partial pressure] in Venous blood
210
1218
1.82
13.56
4.3
3.5
kpa
5.8
5.8
0.09
202
1178
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
89
374
2.45
13.49
3.6
2.3
g/l
0.3
0.0
0.47
81
346
(3012544) pH of Venous blood
214
1251
1.80
13.46
4.2
3.5
—
7.4
—
0
13
(3018418) pH of Serum or Plasma
552
4085
1.50
13.40
4.0
3.8
ph
7.4
7.4
0.28
36
918
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
451
2.31
13.37
3.3
2.3
g/l
10.6
10.3
0.19
83
392
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
160
3.25
13.33
1.2
1.2
u/ml
257.5
246.8
0.11
37
102
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
97
427
2.34
13.27
3.4
2.4
g/l
0.9
0.8
0.12
84
365
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1483
13334
1.58
13.11
5.5
4.3
mmol/l
6.0
6.0
0.79
1308
11963
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
172
3.14
13.11
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
689
5347
1.46
13.09
4.9
4.4
%
21.3
22.3
0.89
365
2801
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
95
418
2.34
13.02
1.9
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
201
1165
1.81
12.99
3.2
2.0
g/l
0.2
0.2
0.24
186
1070
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
90
387
2.39
12.98
3.4
2.3
g/l
37.2
37.1
0.05
76
338
(3017143) Hepatitis C virus Ab [Presence] in Serum
192
1101
1.83
12.85
2.1
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
290
1876
1.65
12.62
1.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
889
7271
1.43
12.57
2.8
2.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
84
357
2.42
12.44
3.6
2.4
g/l
0.0
0.0
0.49
77
329
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
54
183
3.01
12.42
1.8
1.3
u/ml
110.4
100.5
0.46
11
37
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
31
6.51
12.38
2.7
1.9
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
83
352
2.42
12.36
3.6
2.4
g/l
0.0
0.0
0.00
76
328
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1439
12908
1.53
12.28
4.3
3.8
mmol/l
1.3
1.3
0.19
1254
11631
(3029937) Albumin [Presence] in Urine by Test strip
240
3675
0.60
12.04
3.8
3.4
estimate
0.0
0.0
1.08
52
1262
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
79
332
2.44
12.00
1.4
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
325
2191
1.59
11.90
1.2
1.2
u/ml
0.8
2.2
3.87
55
618
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
152
830
1.91
11.85
1.7
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1492
13525
1.54
11.76
4.8
4.2
mmol/l
4.5
4.6
3.49
1319
12387
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
200
2.86
11.75
1.3
1.3
—
—
—
0
0
(4010399)
147
798
1.92
11.66
1.5
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
103
3.65
11.63
2.2
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
185
1084
1.79
11.51
2.6
2.6
ng/l
265.6
215.0
0.61
169
1001
(46235355) HIV 1 and 2 tests - Meaningful Use set
245
1560
1.66
11.28
2.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
388
2.28
11.15
1.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1478
13432
1.51
10.89
5.0
4.2
mmol/l
1.4
1.4
0.19
1301
12206
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
137
745
1.91
10.81
6.1
3.2
kpa
5.0
5.2
1.53
125
690
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1104
9522
1.40
10.77
3.7
3.5
pmol/l
14.6
14.8
2.26
965
8470
(3014271) Vancomycin [Susceptibility]
20
36
5.61
10.70
2.6
3.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
294
2.44
10.68
1.1
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
220
1383
1.67
10.62
1.9
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
78
345
2.32
10.60
7.8
2.9
g/l
0.3
0.2
0.44
49
165
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
125
666
1.94
10.49
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
217
1366
1.67
10.42
2.0
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
24
6.72
10.19
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
134
738
1.88
10.18
6.1
3.2
ph
7.4
7.4
—
8
151
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
102
512
2.05
10.13
4.0
3.4
u/ml
45.1
2726.7
0.77
88
437
(3027801) Oxygen [Partial pressure] in Arterial blood
238
1546
1.62
10.08
8.6
7.0
kpa
12.5
12.2
0.47
225
1478
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
238
1547
1.62
10.06
8.5
7.0
kpa
5.0
5.1
0.06
225
1482
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
92
452
2.09
9.69
1.5
1.7
u/l
36.7
38.1
0.24
74
392
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
92
3.52
9.63
4.5
2.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
168
1009
1.73
9.58
3.4
2.8
kpa
5.1
4.4
2.04
158
968
(3013512) EKG study
499
3824
1.42
9.51
4.4
3.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
26
6.20
9.46
1.1
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
26
6.20
9.46
2.1
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
129
719
1.85
9.45
6.1
3.2
mmol/l
0.9
2.2
4.24
99
530
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
117
634
1.90
9.35
2.4
2.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
214
2.57
9.34
10.5
3.4
iu/ml
868.8
8670.1
0.44
19
26
(3003396) Base excess in Arterial blood by calculation
235
1551
1.59
9.30
8.6
7.0
mmol/l
0.2
0.8
1.46
191
1228
(3017446) Testosterone [Moles/volume] in Serum or Plasma
172
1051
1.70
9.22
2.1
2.0
nmol/l
11.1
12.2
0.90
142
918
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
90
3.49
9.21
1.6
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
75
347
2.21
9.20
1.7
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
137
2.96
9.10
1.1
1.2
u/ml
2.8
3.6
0.42
21
59
(3021589) Normoblasts [#/volume] in Blood
734
6039
1.36
8.98
8.0
9.9
e9/l
0.0
0.0
1.52
549
4750
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
166
2.75
8.96
4.6
2.1
—
828.4
—
0
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
58
243
2.43
8.94
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
31
92
3.41
8.91
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
92
3.41
8.91
1.7
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
149
885
1.74
8.84
2.7
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
69
3.81
8.79
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
176
1097
1.67
8.76
3.2
2.5
e9/l
65.7
65.3
0.06
134
787
(3017732) Neutrophils [#/volume] in Blood
130
745
1.80
8.72
3.3
2.8
e9/l
4.2
4.2
0.05
72
575
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
89
3.41
8.64
1.7
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
40
142
2.86
8.56
4.2
3.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
174
1088
1.66
8.55
2.8
2.4
g/l
65.7
66.2
0.33
151
986
(3024928) Oxygen saturation in Venous blood
63
282
2.28
8.39
2.5
2.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
30
91
3.33
8.35
1.7
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
524
4128
1.38
8.30
3.9
2.9
mmol/l
7.1
7.9
4.54
400
3437
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
222
1485
1.56
8.27
1.7
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
30
92
3.30
8.22
1.7
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
64
293
2.23
8.09
1.2
1.5
ug/g
291.8
249.5
0.74
39
173
(40768443) Skin Pathology biopsy report
101
551
1.88
7.94
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
125
729
1.77
7.92
1.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
35
4.89
7.89
5.5
2.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
29
90
3.26
7.81
2.0
3.4
%
64.0
55.6
1.11
21
55
(3020682) Albumin/Creatinine [Ratio] in Urine
534
4254
1.36
7.80
4.5
3.8
mg/mmol
13.1
8.3
0.83
299
2761
(40768446) Kidney Pathology biopsy report
18
40
4.53
7.65
2.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
36
4.76
7.64
1.2
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
36
4.76
7.64
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
36
4.76
7.64
1.2
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
36
4.76
7.64
1.2
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
57
255
2.27
7.63
1.4
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
1281
0.49
7.62
3.8
3.7
mmol/l
1.2
1.2
0.21
60
1085
(3044889) 12 lead EKG panel
1125
10000
1.32
7.56
3.9
3.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
22
5.94
7.38
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
351
0.20
7.37
4.1
3.1
%
55.9
58.4
—
7
351
(3012516) Albumin [Mass/volume] in Urine
504
4012
1.35
7.32
4.0
3.0
mg/l
424.6
229.7
0.44
288
2615
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
479
3788
1.36
7.25
3.2
2.3
u/l
55.4
59.7
1.27
427
3460
(3044927) Protein electrophoresis panel - Urine
31
105
2.99
7.24
1.3
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
38
146
2.64
7.06
1.2
1.2
u/ml
1.2
4.2
1.02
14
45
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
403
5107
0.73
7.06
3.7
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
194
1309
1.54
6.94
1.7
1.6
%
1.5
1.5
0.11
153
1116
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
62
299
2.11
6.93
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
126
768
1.69
6.85
10.0
9.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
61
294
2.11
6.84
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
61
294
2.11
6.84
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
62
301
2.10
6.82
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
62
302
2.09
6.76
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
335
0.21
6.75
4.1
2.9
e9/l
3.5
4.3
—
7
335
(3052851) Hemolysis interference index of Serum or Plasma
81
436
1.90
6.68
3.9
3.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
181
2.41
6.64
1.6
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
209
1447
1.50
6.63
1.3
1.3
titre
721.0
441.5
0.83
39
284
(3002173) Hemoglobin [Mass/volume] in Arterial blood
188
1277
1.53
6.53
9.8
7.7
g/l
122.5
122.1
0.08
181
1237
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
25
5.23
6.49
3.4
1.2
ug/l
56.8
51.5
0.14
13
25
(3004616) Nuclear Ab [Presence] in Serum
29
101
2.90
6.48
1.3
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
20
56
3.60
6.32
3.9
4.0
nmol/l
206.0
105.2
0.54
20
56
(3045414) Leukocytes [Presence] in Urine
79
430
1.87
6.32
2.0
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
27
92
2.96
6.28
1.1
1.2
—
—
—
0
0
(4306422)
33
126
2.65
6.24
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
127
797
1.64
6.19
2.5
2.5
g/l
10.8
10.8
0.01
116
728
(1761868) Lipid panel - Serum or Plasma
421
5207
0.75
6.06
2.5
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
197
1373
1.49
6.05
1.6
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
140
2.53
6.04
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
35
4.31
6.03
1.6
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
35
4.31
6.03
1.6
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
358
2779
1.36
5.99
2.8
3.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
437
0.25
5.92
3.7
4.7
kpa
7.7
8.4
0.94
11
431
(3013290) Carbon dioxide [Partial pressure] in Blood
11
435
0.25
5.88
3.7
4.7
kpa
5.2
5.0
0.47
11
429
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
27
96
2.84
5.84
2.3
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
26
91
2.88
5.79
5.3
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
252
1857
1.41
5.76
1.2
1.2
iu/ml
27.9
37.6
0.90
62
560
(3016502) Oxygen saturation in Arterial blood
196
1381
1.47
5.70
9.5
7.3
%
95.5
95.3
0.07
190
1333
(3014051) Protein [Presence] in Urine by Test strip
41
183
2.27
5.60
2.5
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
52
3.49
5.45
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
30
4.36
5.30
1.3
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
30
4.36
5.30
1.3
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
106
664
1.63
5.24
2.5
2.3
au/ml
30.2
14.7
—
7
42
(4035726)
178
1255
1.46
5.17
1.4
1.4
—
—
—
0
0
(4034850)
26
622
0.41
5.17
9.6
9.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
31
4.22
5.09
1.3
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
19
5.29
5.04
1.5
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
38
173
2.22
4.98
2.4
2.9
%
1.0
1.6
0.50
30
132
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
57
304
1.90
4.92
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
47
3.43
4.75
1.6
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
47
3.43
4.75
1.6
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
38
177
2.17
4.73
1.7
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
50
259
1.96
4.71
1.4
1.6
e6/l
10114.0
18192.0
0.97
32
179
(3051611) Lipemic interference index of Serum or Plasma
34
154
2.23
4.54
4.7
3.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
46
235
1.98
4.52
1.3
1.2
u/ml
1.7
1.7
—
6
14
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
93
2.60
4.48
1.3
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
49
3.29
4.47
3.1
2.6
%
36.4
39.1
—
7
14
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
82
2.70
4.42
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
129
1842
0.68
4.38
3.0
3.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
47
245
1.94
4.37
1.1
1.1
u/ml
1.0
6.1
—
5
37
(3019832) Treponema pallidum Ab [Presence] in Serum
97
626
1.58
4.30
2.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
254
1.91
4.28
1.2
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
240
1.94
4.27
1.3
1.2
u/ml
2.5
9.3
—
7
29
(3028026) IgM [Mass/volume] in Serum or Plasma
100
652
1.56
4.24
2.4
2.0
g/l
1.9
1.4
0.60
91
595
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
49
263
1.89
4.19
1.4
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
15
46
3.28
4.19
1.3
1.1
nmol/l
142.1
137.0
0.15
15
46
(3010421) pH of Blood
20
486
0.41
4.19
3.6
4.5
ph
7.4
7.4
0.29
11
430
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
41
3.43
4.18
1.3
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
229
1753
1.35
4.15
1.2
1.2
u/ml
4.8
15.3
3.44
59
666
(4094501)
61
352
1.76
4.14
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
37
181
2.07
4.11
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
16
52
3.10
4.08
1.3
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
683
1.54
4.07
2.1
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
48
260
1.87
4.01
1.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
72
440
1.66
3.99
2.3
2.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
232
1.92
3.98
3.5
3.0
nmol/l
0.7
0.8
1.15
30
187
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
178
2.04
3.90
1.4
1.4
e6/l
192006.6
70373.2
0.33
28
99
(3041096) Erythrocytes [Presence] in Urine by Automated
304
3733
0.78
3.88
3.3
3.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
212
1626
1.34
3.80
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
34
168
2.04
3.71
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
43
231
1.88
3.70
1.8
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
169
2.03
3.65
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
26
116
2.26
3.65
1.4
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
183
1.99
3.64
2.8
1.7
u/l
570.0
3804.2
0.92
13
70
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
85
2.49
3.63
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
50
284
1.78
3.62
1.9
1.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
12
35
3.44
3.62
2.4
2.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
67
415
1.64
3.56
4.3
3.2
mg/l
39.4
54.6
0.42
60
303
(3028271) Lactate [Moles/volume] in Capillary blood
10
309
0.32
3.55
1.4
1.8
mmol/l
1.8
1.8
—
10
302
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
124
2.19
3.55
1.7
1.1
u/l
55.6
59.6
0.12
14
88
(3036481) Cortisol [Moles/volume] in Serum or Plasma
135
974
1.42
3.53
2.5
2.2
nmol/l
415.5
377.3
1.50
122
899
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
75
482
1.58
3.44
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
16
58
2.77
3.42
3.6
1.7
e6/l
696.2
665.1
—
5
23
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
19
76
2.52
3.38
1.2
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
19
76
2.52
3.38
1.8
1.6
u/ml
13.8
24.3
—
8
18
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
19
76
2.52
3.38
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
19
76
2.52
3.38
1.2
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
29
141
2.07
3.32
2.0
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
66
416
1.61
3.29
4.4
3.2
mg/l
53.5
68.7
0.36
59
302
(40767503) Oxygen content in Capillary blood by calculation
18
408
0.44
3.24
3.4
2.5
%
15.0
16.2
0.52
13
204
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
265
1.75
3.21
2.2
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
72
2.51
3.21
2.7
2.1
%
18.2
12.8
1.04
12
26
(3023199) Leukocytes [#/volume] in Pleural fluid
36
192
1.89
3.21
1.4
1.4
e6/l
1002.8
1845.2
1.46
30
123
(3028433) Virus identified in Specimen by Culture
10
28
3.59
3.19
1.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
88
597
1.50
3.19
3.7
3.1
—
—
—
0
0
(3000492) Spirometry study
158
1192
1.36
3.18
1.6
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
91
2.32
3.17
1.2
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
117
2.15
3.16
1.0
1.0
u/ml
1.9
4.1
0.53
13
43
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
67
2.55
3.13
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
67
2.55
3.13
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
67
2.55
3.13
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
20
4.52
3.11
1.1
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
117
844
1.41
3.09
3.0
3.0
g/l
128.9
129.7
0.13
112
817
(21494434) Karyotype in Bone marrow
22
99
2.24
3.06
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
16
5.02
3.05
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
68
2.51
3.04
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
68
2.51
3.04
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
68
2.51
3.04
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
229
2830
0.78
3.04
4.1
4.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
424
0.47
3.04
4.0
4.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
46
271
1.72
2.99
4.4
2.2
umol/l
30.0
35.4
1.29
40
219
(3004716) Salmonella sp identified in Stool by Organism specific culture
75
500
1.52
2.97
1.3
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
20
88
2.29
2.94
3.1
2.0
e9/l
1.2
1.0
0.28
13
58
(4268621)
20
88
2.29
2.94
2.4
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
23
109
2.12
2.85
1.4
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
30
158
1.91
2.81
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
277
1.68
2.78
1.8
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
84
2.28
2.77
1.4
2.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
35
195
1.81
2.77
1.5
1.3
mmol/l
57.9
61.1
0.19
28
147
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
138
1.97
2.75
1.5
1.5
%
62.7
60.5
0.09
16
80
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
6
8.35
2.75
1.2
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
562
4992
1.18
2.71
3.7
3.4
ng/l
31.1
60.3
2.71
372
3560
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
197
1.79
2.68
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
92
2.19
2.67
1.4
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
24
3.76
2.67
2.8
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
99
714
1.41
2.66
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
80
2.26
2.61
1.1
1.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
7
15
4.68
2.59
1.0
2.1
%
113.6
96.6
—
7
15
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
7
7.16
2.55
1.0
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
11
5.47
2.54
3.2
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
101
2.09
2.53
1.3
1.3
—
—
—
0
0
(4015189)
10
33
3.04
2.52
2.2
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
85
603
1.43
2.52
2.1
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
49
309
1.60
2.51
1.3
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
255
3041
0.81
2.46
1.6
1.7
pmol/l
36097997.6
37941232.6
0.02
205
2467
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
67
458
1.48
2.41
1.6
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
70
2.30
2.41
2.8
2.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
12
5.01
2.40
3.2
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
120
912
1.34
2.37
9.3
6.9
mmol/l
24.6
24.6
0.03
120
905
(3011288) Drugs identified in Urine by Screen method
22
111
1.99
2.36
2.5
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
118
1.96
2.35
1.0
1.0
u/ml
0.2
1.7
—
10
43
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
141
1.86
2.28
1.1
1.1
u/ml
0.2
1.6
—
9
51
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
23
3.49
2.27
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
48
312
1.55
2.20
1.3
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
36
2.79
2.20
2.6
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
33
195
1.70
2.20
1.4
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
48
2.51
2.18
1.8
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
122
1.90
2.16
1.0
1.0
u/ml
1.1
3.0
—
7
57
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
48
314
1.54
2.15
1.5
1.4
g/l
1.2
1.2
0.19
48
302
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
221
1.64
2.09
1.7
1.2
u/l
12.0
10.3
0.27
30
177
(3021788) Differential panel - Synovial fluid
36
222
1.63
2.06
1.3
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
20
3.51
2.05
1.0
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
90
2.01
2.00
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
57
2.29
1.97
1.4
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
27
2.97
1.93
2.8
1.1
—
—
—
0
0
(4133840)
8
28
2.86
1.86
1.4
1.1
—
—
—
0
0
(1002224) Polysomnography panel
61
436
1.41
1.81
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
101
1.89
1.81
1.0
1.0
u/ml
0.6
1.8
—
6
30
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
94
1.92
1.80
1.1
1.0
u/ml
0.1
1.3
—
6
25
(44790047)
20
109
1.84
1.77
1.8
1.2
—
—
—
0
0
(44790048)
20
109
1.84
1.77
1.8
1.2
—
—
—
0
0
(44806118)
20
109
1.84
1.77
1.8
1.2
—
—
—
0
0
(44790049)
20
109
1.84
1.77
1.8
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
51
355
1.45
1.75
2.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
66
888
0.73
1.71
2.5
2.4
ml/min/173m2
59.9
65.4
0.57
27
370
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
23
133
1.74
1.70
1.2
1.3
mmol/l
9.3
7.6
0.66
15
93
(40761535) Cells panel - Urine sediment
113
899
1.27
1.67
4.4
2.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
25
149
1.69
1.67
1.0
1.1
—
10.2
—
0
11
(3003434) Protein [Mass/volume] in Pleural fluid
36
236
1.54
1.65
1.4
1.4
g/l
30.2
32.1
0.41
30
213
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
423
3807
1.14
1.65
1.6
1.6
mmol/l
1.2
1.3
1.41
400
3052
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
142
1.70
1.65
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
198
1.58
1.60
1.6
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
70
2.01
1.59
1.4
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
21
121
1.74
1.58
3.0
1.9
%
10.6
11.3
0.39
21
121
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
20
3.01
1.58
1.2
1.0
u/ml
35.5
45.0
—
6
20
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
26
2.70
1.58
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
22
129
1.71
1.57
1.5
1.2
nmol/l
0.7
0.6
1.13
22
122
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
157
0.44
1.55
1.1
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
71
1.98
1.54
1.2
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
44
2.28
1.53
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
22
130
1.70
1.53
1.3
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
2.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
20
116
1.73
1.49
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
116
1.73
1.49
1.5
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
37
2.44
1.48
1.0
1.1
miu/ml
1716.1
1535.2
—
9
37
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
94
1.82
1.47
2.8
1.4
g/l
1.0
1.0
0.08
17
94
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
38
2.37
1.45
3.3
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
15
80
1.88
1.44
1.0
1.0
mg/l
255.1
295.0
—
10
72
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
23
2.61
1.36
4.3
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
127
1.66
1.36
1.2
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
17
2.95
1.36
3.8
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
42
2.15
1.33
1.1
1.0
—
—
—
0
0
(4281824)
22
136
1.63
1.32
1.2
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
40
0.00
1.32
0.0
2.5
—
6.8
—
0
18
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
35
242
1.45
1.30
4.7
1.5
nmol/l
0.9
0.8
0.11
26
215
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
18
2.78
1.28
10.6
9.3
mmol/l
6.5
5.5
—
5
18
(3020891) Body temperature
39
541
0.71
1.28
6.4
4.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
97
787
1.25
1.27
3.5
2.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
626
1.27
1.26
2.6
3.6
pmol/l
4.2
4.4
1.87
71
551
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
90
726
1.25
1.24
1.4
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
25
2.40
1.24
1.3
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
49
2.05
1.22
1.4
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
19
2.64
1.21
3.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
37
2.17
1.21
1.6
2.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
43
314
1.38
1.21
1.5
1.6
iu/ml
0.0
16.1
0.51
15
69
(4027681)
8
38
2.11
1.18
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
64
1.88
1.18
2.2
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
57
1.94
1.17
1.2
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
57
1.94
1.17
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
49
369
1.34
1.15
1.8
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
87
1.73
1.15
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
300
1.38
1.15
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
216
1.44
1.14
1.4
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
342
0.67
1.12
2.3
2.4
ug/min
115.8
76.4
0.23
14
212
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
58
1.90
1.12
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
21
135
1.56
1.11
1.8
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
135
1.56
1.11
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
14
231
0.60
1.08
1.3
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
32
2.19
1.08
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
42
313
1.35
1.07
4.6
3.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
47
1.92
1.02
1.3
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
16
99
1.62
1.00
1.1
1.1
titre
355.0
173.5
—
6
17
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
50
1.80
0.96
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
50
1.80
0.96
1.1
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
108
1.58
0.96
1.4
1.2
e6/l
37405.8
136346.9
—
9
84
(3023419) Bacteria identified in Sputum by Culture
22
149
1.48
0.95
4.9
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
25
174
1.44
0.95
1.3
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
22
317
0.69
0.95
3.4
2.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
120
0.50
0.93
1.3
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
70
1.72
0.92
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
70
1.72
0.92
1.1
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
55
1.82
0.92
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
228
0.66
0.86
4.0
3.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
72
1.67
0.85
1.4
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
45
1.78
0.84
2.8
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
57
1.76
0.83
1.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
65
1.70
0.82
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
65
1.70
0.82
1.3
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
97
1.55
0.81
2.8
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
15
97
1.55
0.81
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
47
1.71
0.80
1.6
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
39
303
1.29
0.80
1.6
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
243
2656
0.90
0.79
3.5
3.4
kg/l
1.0
1.0
0.54
41
387
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
25
0.00
0.79
0.0
3.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
37
286
1.30
0.79
1.6
1.7
nmol/l
51.9
43.0
0.63
32
278
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
30
225
1.34
0.78
1.2
1.2
u/l
73.0
34.9
0.73
25
184
(1617658) Protocol used for examination of sentinel lymph nodes
5
98
0.51
0.78
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
192
1.36
0.75
1.3
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
75
1.60
0.75
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
196
0.66
0.74
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
193
1.35
0.73
1.3
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
100
1.50
0.73
1.7
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
25
2.00
0.72
1.4
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
405
3805
1.08
0.72
1.4
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
56
1.61
0.72
1.1
2.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
68
1.62
0.71
1.5
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
76
1.58
0.71
4.6
4.4
u/ml
21.1
61.7
1.15
12
76
(3028300) Cannabinoids [Presence] in Urine
26
194
1.35
0.71
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
194
1.35
0.71
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
151
1.40
0.71
1.1
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
26
1.93
0.70
1.4
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
27
204
1.33
0.69
1.5
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
27
1.85
0.68
1.0
1.5
%
19.8
21.0
—
5
21
(40768806) Pleura Pathology biopsy report
26
196
1.33
0.67
1.8
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
75
641
1.18
0.67
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
384
1.23
0.67
3.9
3.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
17
119
1.43
0.67
1.7
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
38
303
1.26
0.66
1.8
3.8
u/ml
27.0
459.6
0.71
32
284
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
78
1.54
0.65
1.3
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
78
1.54
0.65
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
225
0.71
0.65
2.0
2.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
10
62
1.62
0.65
1.2
1.0
ng/l
376.0
366.3
—
5
47
(40768441) Liver Pathology biopsy report
13
87
1.50
0.63
2.5
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
10
63
1.59
0.61
1.2
1.0
ng/l
49.5
48.5
—
5
47
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
10
63
1.59
0.61
1.2
1.0
ng/l
703.8
622.3
—
5
45
(3006462) Nitrate [Presence] in Urine
11
72
1.53
0.59
2.4
2.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
201
1.30
0.59
1.5
1.5
e6/l
4.9
22.6
0.52
16
143
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
23
0.00
0.58
0.0
3.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
193
1.30
0.57
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
26
202
1.29
0.57
1.5
1.5
e6/l
270.1
872.3
0.72
18
156
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
125
0.64
0.54
1.4
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
231
1.26
0.54
1.2
1.2
miu/ml
288.2
215.8
—
10
97
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
62
1.45
0.53
1.4
18.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
232
1.25
0.52
1.7
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
1.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
50
426
1.18
0.50
1.3
1.7
mg/l
3.7
4.0
0.06
35
298
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
40
334
1.20
0.50
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
171
1.29
0.50
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
67
1.50
0.49
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
46
390
1.18
0.49
6.3
4.9
mmol/l
1.6
1.3
0.72
39
341
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
110
1.37
0.48
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
108
0.65
0.48
1.3
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
190
1.27
0.48
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
50
1.40
0.45
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
192
1.25
0.45
1.8
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
174
1.27
0.45
2.4
2.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
51
1.37
0.44
1.9
2.1
umol/l
72.4
49.4
—
7
36
(3039443) Prostate specific Ag panel - Serum or Plasma
41
349
1.18
0.43
1.7
1.7
—
—
—
0
0
(4211845)
11
78
1.41
0.43
2.4
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
123
1.30
0.40
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
34
1.47
0.40
3.0
6.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
159
1.26
0.40
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
159
1.26
0.40
1.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
35
1.43
0.39
3.6
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
376
0.85
0.37
2.4
3.2
mmol/l
24.1
25.0
1.00
25
345
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
143
1.26
0.37
1.4
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
71
641
1.11
0.35
4.2
3.1
mmol/l
24.9
25.0
0.09
66
622
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
189
0.79
0.34
2.0
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
45
1.33
0.33
1.8
2.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
46
519
0.88
0.33
1.8
1.8
ug/l
1.1
2.8
1.11
38
457
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
110
1.27
0.31
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
97
0.72
0.31
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
75
1.34
0.30
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
120
1.25
0.30
1.7
1.2
nmol/l
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
102
1.28
0.30
2.2
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
176
1.20
0.29
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
119
1116
1.07
0.28
1.8
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
63
1.27
0.27
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
149
1410
1.06
0.27
1.6
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
192
0.83
0.25
1.2
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
22
188
1.17
0.25
1.2
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
107
1006
1.07
0.25
3.6
3.4
%
0.0
0.2
2.92
35
271
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
245
1.15
0.24
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
77
1.17
0.24
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
81
0.74
0.24
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
94
0.74
0.22
2.4
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
78
833
0.93
0.21
7.1
6.3
mmol/l
24.3
24.3
0.02
70
777
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
4.2
2.5
umol/l
33.8
30.7
—
5
32
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
14.3
—
0
11
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
367
0.90
0.21
2.0
2.3
g/l
125.6
129.5
0.27
18
281
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.8
—
23.8
—
0
12
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
80
1.25
0.20
3.3
1.7
u/l
0.0
10.2
—
5
47
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
50
1.20
0.19
1.2
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
38
346
1.10
0.19
1.7
1.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
14
118
1.19
0.19
1.2
1.2
—
31.5
—
0
6
(3009261) Glucose [Presence] in Urine by Test strip
646
6555
0.98
0.17
3.3
3.2
estimate
0.0
0.0
1.08
47
1286
(44813793)
8
71
1.13
0.16
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
71
1.13
0.16
6.8
6.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
110
1056
1.04
0.15
3.6
3.3
%
0.9
1.0
0.26
35
296
(3035880) pH of Pleural fluid
8
97
0.82
0.13
1.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
47
443
1.06
0.12
1.1
1.1
—
199.3
—
0
13
(3025159) Blasts/100 leukocytes in Blood
91
946
0.96
0.12
3.8
3.5
%
0.0
0.1
1.36
27
234
(40768795) Lymph node Pathology biopsy report
12
137
0.88
0.12
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
640
6464
0.98
0.10
4.9
4.2
estimate
0.0
0.0
0.80
53
1361
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
47
1.06
0.09
1.2
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
88
908
0.97
0.09
5.1
4.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
89
863
1.03
0.09
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
61
0.82
0.08
1.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
154
0.91
0.08
1.4
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
71
0.84
0.07
3.8
3.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
153
0.91
0.07
1.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
54
559
0.96
0.06
1.7
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
69
710
0.97
0.06
1.2
1.2
iu/ml
326.6
172.0
0.41
18
272
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
152
0.92
0.06
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
152
0.92
0.06
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
151
0.93
0.05
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
282
0.96
0.04
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
298
1.04
0.04
1.0
1.1
—
—
—
0
0
(4062490)
10
91
1.10
0.04
1.9
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
210
1.05
0.03
1.3
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
641
6432
0.99
0.03
3.2
3.1
estimate
0.0
0.0
0.00
48
1346
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
112
1.07
0.03
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
98
970
1.01
0.02
3.3
3.3
%
1.0
0.6
0.31
23
221
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
157
0.96
0.01
1.5
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
11
116
0.95
0.00
1.1
1.6
nmol/l
0.7
0.3
0.74
11
87
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
135
0.96
0.00
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
113
1125
1.00
0.00
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
174
0.98
0.00
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
98
1.02
0.00
1.9
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
133
0.98
0.00
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
133
0.98
0.00
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
203
0.99
0.00
1.8
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
263
0.99
0.00
1.1
1.9
iu/l
4.1
5.0
—
7
96
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
17.0
14.7
nmol/l
1368.4
1371.9
—
5
52
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
270
1.00
0.00
1.4
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.8
—
0
5
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
69
1.01
0.00
2.4
1.9
nmol/l
15.7
16.8
—
7
64
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
7.8
—
12.8
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
7.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
201.5
—
0
6
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
2.0
—
2.0
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
7
72
0.97
0.00
1.3
1.4
—
5.7
—
0
19
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
55
0.91
0.00
1.0
1.4
mmol/l
5.0
3.4
—
5
48

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS – Special screening examination for neoplasms

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).